DCIS and Mammography

NEW YORK, June 19 (Praxis Press) Most women accept that a false positive result can occur with screening mammography. Few, however, have heard of ductal carcinoma in situ (DCIS), a potentially non-progressive cancer also detected by screening mammography. Schwartz and colleagues surveyed 479 women, aged 18-97 years, without a history of breast cancer (see paper). They found that women are aware of the possibility of false positive results and view them as an acceptab

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, June 19 (Praxis Press) Most women accept that a false positive result can occur with screening mammography. Few, however, have heard of ductal carcinoma in situ (DCIS), a potentially non-progressive cancer also detected by screening mammography. Schwartz and colleagues surveyed 479 women, aged 18-97 years, without a history of breast cancer (see paper). They found that women are aware of the possibility of false positive results and view them as an acceptable consequence of screening mammography. In contrast, very few women knew that screening could detect cancers, such as DCIS, that may never progress. The women felt that such information would be relevant to them, however. Women should be informed about the possible detection of DCIS when undergoing mammography.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform